News & Media


7 Jul, 2020

The ACI to Partner with VOXPO for B2C and B2B CBD Event

The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.

19 Jun, 2020

The ACI Responds to Global Regulatory Calls for Evidence of CBD Safety by Launching Study Consortium

The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.

17 Jun, 2020

ACI Bolsters Regulatory and Compliance Unit To Support UK CBD Industry

The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.

In the Media

15 Jul, 2020

[Food Navigator] UK cannabinoid industry spots opportunity as EC considers reclassifying CBD a narcotic

The UK could be set to emerge as a global leader in the research and development of CBD as a food ingredient after the news that the European Commission has postponed the Novel Food applications of non-synthetic CBD products as it decides whether to class non-synthetic CBD as a narcotic.

2 Jul, 2020

[Nutra Ingredients] CBD Novel Foods deadline fast approaching as firms embrace regulatory challenges

With UK FSA (Food Standards Agency) setting 31 March as the deadline for firms to have validated novel foods application for its #CBD products, how are firms responding to this challenge in the current climate?’

30 Jun, 2020

The ACI Partners with The ReLeaf CBD Podcast

The ACI is pleased to announce a partnership with The CBD Podcast by ReLeaf. The partnership commences with an interview with members of The ACI’s Regulatory and Compliance Unit, which is headed up by Dr Parveen Bhatarah. The team, which includes several new hires, ensures that our members are fully compliant with laws relating to cannabinoids.